Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes
|
|
- Kerry Stevenson
- 5 years ago
- Views:
Transcription
1 721938DSTXXX / Journal of Diabetes Science and TechnologyHarrington et al research-article2017 Original Article Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes Journal of Diabetes Science and Technology 2017, Vol. 11(5) Diabetes Technology Society Reprints and permissions: sagepub.com/journalspermissions.nav DOI: journals.sagepub.com/home/dst Kara R. Harrington, PhD 1, Claire T. Boyle, MS 2, Kellee M. Miller, PhD 2, Marisa E. Hilliard, PhD 3, Barbara J. Anderson, PhD 3, Michelle Van Name, MD 4, Linda A. DiMeglio, MD, MPH 5, and Lori M. Laffel, MD, MPH 1, for the T1D Exchange Clinic Network Abstract Background: This study investigated unique burdens experienced by parents of young children with type 1 diabetes in the context of contemporary diabetes management. Methods: Self-report surveys and medical record information from the T1D Exchange clinic registry were used. Parental burden and family impact scores were tabulated across demographic and clinical characteristics, overall and according to age group (<4, 4-<6, and 6-<7 years). Results: The mean age of the 597 children was 5.2 ± 1.2 years (n = 111 <4 years, n = <6 years, and n = <7 years) and mean duration of diabetes was 2.4 ± 1.1 years. Mean hemoglobin A1c was 8.2% ± 1.1%. Approximately one-third (31%) reported their child was currently using CGM and over half (58%) reported using insulin pumps. The most frequently endorsed parent-reported burdens of diabetes were worrying about child having a low blood sugar (74%), about the future and possibility of serious complications (70%), and feeling upset when their child s diabetes management is off track (61%). Areas endorsed for negative family impact were diminished amount or quality of sleep for family members (59%) and need for flexible working arrangements to help care for their child (55%). Conclusions: Substantial burdens remain for parents of young children with type 1 diabetes, despite the availability of advanced technologies for diabetes management. Keywords type 1 diabetes, young children, Problem Areas in Diabetes Survey, Family Impact Survey, T1D Exchange Clinic Registry Parents of young children with type 1 diabetes face significant stress and burden. 1,2 A majority, if not all, of diabetes management is the responsibility of the parents, and there are many challenges to diabetes management in children aged 7 and under. Young children are rapidly emerging in the realms of physical, cognitive, social, and emotional development. These changes impact the interaction between children and their caregivers as they navigate diabetes management. In addition, primary caregivers of young children need to trust others with diabetes management responsibilities as the child is introduced to child care and school settings. 3 Each developmental stage of young childhood has unique challenges and issues pertaining to diabetes management. Given this, it is important to consider the experience of parents caring for children with type 1 diabetes at different developmental stages. There is ample evidence that suggests parents of young children with type 1 diabetes experience emotional distress while caring for their child. 4-7 There have been calls for research to refine our knowledge of parental burden and distress to inform the design of interventions for families of young children with type 1 diabetes. 8,9 Parental coping strategies and distress have 1 Joslin Diabetes Center, Boston, MA, USA 2 Jaeb Center for Health Research, Tampa, FL, USA 3 Baylor College of Medicine and Texas Children s Hospital, Houston, TX, USA 4 Yale School of Medicine, New Haven, CT, USA 5 Indiana University School of Medicine, Indianapolis, IN, USA Corresponding Author: Claire T. Boyle, MS, Jaeb Center for Health Research, Amberly Dr, Ste 350, Tampa, FL 33647, USA. T1DStats6@jaeb.org Note: This article has been substantially revised from the original submission, which was published in the OnlineFirst section of JDST in February 2017.
2 Harrington et al 981 implications for treatment adherence, quality of life, and family functioning. Interventions have been developed to help parents cope with caring for young children with type 1 diabetes However, few of these psychosocial interventions have been focused on the adoption of advanced diabetes technology in very young children. Diabetes technologies have improved substantially in the past several decades, with tools such as smart insulin pumps with bolus calculators and continuous glucose monitors (CGMs). Along with these technical advancements come new challenges and possible burdens, especially for young children and their families. For example, it can be difficult for parents to find real estate on their small children s bodies to attach and secure devices, and other caregivers need to be educated on these devices. 15,16 Thus, it is important to ascertain typical burdens and stresses of parents of young children with diabetes in the contemporary diabetes management era. It is also important to understand how the burdens reported by parents are impacted by use or nonuse of different diabetes technologies, as well as by other demographic factors, such as socioeconomic status. The aim of this study was to understand present-day burdens experienced by parents caring for their young child with type 1 diabetes. We investigated the burden reported by families with children in different age groups, toddlers (under 4 years), preschoolers (4-<6 years), and school age children (6-<7 years) to understand the unique burdens and family impacts at different developmental stages. Children in toddlerhood have limited verbal abilities which make it difficult to convey symptoms, preschool children are entering the school environment for the first time, and school age children and their parents need to establish new relationships with caregivers and rely on them more due to the longer days spent at school. All of these factors may have an impact on reported diabetes burdens. We anticipated that parents of young children with type 1 diabetes would report significant burdens and distress, highlighting the need to explore the factors related to burden and distress and ultimately identify approaches to overcome the challenges reported by parents of young children with type 1 diabetes, especially with potential burdens associated with advanced diabetes technologies. Methods The T1D Exchange Clinic Registry (T1D Exchange) includes 74 endocrinology practices based in the United States, including 58 centers serving youth with type 1 diabetes (see Supplemental Materials). To date, over participants have been enrolled in the registry, and details of the enrollment process, eligibility criteria, and baseline data collection have been previously reported. 17 Data were collected for the clinic registry central database from medical records in addition to questionnaires completed by parents of the young children enrolled in the registry. 17 This report includes 597 young children enrolled in the registry since February 1, 2015, aged less than 7 years with a clinical diagnosis of type 1 diabetes for at least 1 year, whose parent/guardian completed the two surveys assessing the main constructs of interest in this study: parental burden and family impact (described below). Demographic, socioeconomic, and diabetes management factors were obtained from parent/guardian questionnaires. Insulin pump and CGM use were reported by parent/guardian and confirmed by clinic report. The most recent hemoglobin A1c (HbA1c) measurement within 6 months prior to registry enrollment (mean duration of HbA1c measurement prior to enrollment was 7 days) was obtained from the clinic medical record. HbA1c values were measured by point-of-care device or local laboratory. Occurrences of diabetic ketoacidosis (DKA) and severe hypoglycemia (SH) during the 3 months prior to enrollment were reported by parent/guardian. DKA was defined by occurrence of ketoacidosis diagnosed by a doctor requiring a visit to hospital, emergency room, or other health care facility. SH was defined as hypoglycemia resulting in seizure or loss of consciousness. The Problem Areas in Diabetes Survey Parent Revised version (PAID-PR) 18 measures the degree of burden experienced by the parents while managing their child with type 1 diabetes. Parents/guardians were asked to rate their agreement with 18 statements regarding the burden of diabetesrelated issues using a 0 (agree) to 4 (disagree) Likert-type scale. Total score for each participant was the mean of all nonmissing responses reversed scored then multiplied by 25 for a total possible score of 100, with higher scores representing higher parental burden. The Family Impact Survey (FIS) 19 measures a different kind of burden, how often diabetes impacted family life in the past year. Parents were asked to rate how often diabetes negatively affected areas such as school, work, finances, and well-being using a 0 (almost never) to 3 (almost always) Likert-type scale, which was scored for each participant as the mean of all nonmissing responses multiplied by 33.3 for a total score out of 100. Higher FIS scores represent more negative impact of diabetes on the family. Parents had the option of selecting not applicable for any of the responses on the FIS. These values were excluded from tabulations and calculations of the total score. Statistical Analyses For both the PAID-PR and FIS, the mean total score was tabulated according to various demographic and clinical characteristics. The amount of burden and the degree of negative family impact for the individual responses to the PAID-PR and FIS surveys were tabulated overall and according to age group (<4, 4-<6, and 6-<7 years), with presentation of percentages of the sample endorsing various burdens or family impacts. The associations between each mean total score and demographic and clinical characteristics were
3 982 Journal of Diabetes Science and Technology 11(5) Table 1. Cohort Characteristics. Overall N = 597 Ages <4 n = 111 Ages 4-<6 n = 291 Ages 6-<7 n = 195 Age in years 5.2 ± ± ± ± 0.3 Child gender female 277 (46%) 51 (46%) 137 (47%) 89 (46%) Race/ethnicity White non-hispanic 446 (76%) 92 (84%) 214 (75%) 140 (74%) Other 138 (24%) 17 (16%) 71 (25%) 50 (26%) Annual household income $75, (52%) 51 (52%) 129 (50%) 94 (56%) Highest level of parent education High school/ged or less 242 (41%) 32 (29%) 130 (46%) 80 (42%) Associate s or bachelor s degree 195 (33%) 48 (44%) 83 (29%) 64 (33%) Master s, professional, or doctorate degree 148 (25%) 29 (27%) 71 (25%) 48 (25%) Duration of diabetes in years 2.4 ± ± ± ± <3 years 450 (75%) 109 (98%) 223 (77%) 118 (61%) 3-<7 years 147 (25%) 2 (2%) 68 (23%) 77 (39%) Frequency of self-monitoring blood glucose per day 7.1 ± ± ± ± times per day 431 (72%) 82 (74%) 209 (72%) 140 (72%) Current continuous glucose monitor user 185 (31%) 44 (40%) 91 (31%) 50 (26%) Current pump user 337 (58%) 71 (65%) 162 (58%) 104 (56%) Most recent HbA1c 8.2 ± ± ± ± 1.2 <7.5% 144 (24%) 25 (23%) 69 (24%) 50 (26%) Occurrence of at least one SH event in the past 3 months a 42 (7%) 4 (4%) 19 (7%) 19 (10%) Occurrence of at least one DKA event in the past 3 months a 31 (5%) 7 (6%) 16 (5%) 8 (4%) GED, general education development; SD, standard deviation. a Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at least one diabetic ketoacidosis (DKA) event in the past 3 months. assessed overall and according to age group (<4, 4-<6, and 6-<7 years) using t-tests or the Wilcoxon Rank-Sum procedure (or Kruskal-Wallis if >2 levels) as appropriate. An unadjusted linear regression model was used to determine the association with HbA1c. Data analyses were performed using SAS version 9.4 (2011 SAS Institute Inc, Cary, NC). All s are two-sided, and due to multiple comparisons only s <.01 were considered statistically significant. Results Participant Characteristics The mean age of the 597 children was 5.2 ± 1.2 years (n = 111 <4 years, n = <6 years, and n = <7 years) and mean duration of diabetes was 2.4 ± 1.1 years. Mean HbA1c was 8.2% ± 1.1%. Approximately one-third (31%) were identified as current CGM users and more than half (58%) were using insulin pumps. Additional cohort characteristics are shown in Table 1. Survey Tabulations Figures 1 and 2 show the areas in which parents feel most burdened by or experience high negative family impact from their young child s diabetes for each age group. Overall, most parents reported the largest burden of diabetes related to worrying about their child having a low blood sugar (74%). Other areas in which parents felt most burdened by diabetes involved worrying about the future and the possibility of serious complications for their child (70%), feeling upset when their child s diabetes management is off track (61%), worrying that their child will not be taken care of when away from home (57%), and feeling upset when their child s blood sugars are out of range (54%). Parents felt least burdened about their child being excluded from activities/ events because of diabetes (13%), having difficulty dealing with school staff (12%), their child being deprived regarding food and meals (11%), and feeling discouraged with their child s diabetes treatment plan (5%). Areas in which parents experienced frequent negative family impact were diminished amount or quality of sleep for family members (59%) and the need for flexible working arrangements to help care for their child (55%). Problems with regular school attendance (7%), negative impact of diabetes on school performance (5%), and the inability to participate in activities or trips (5%) were the areas in which parents reported the lowest impact on their family life. Parental Burden Results The mean total PAID score was 45.7 ± 18.9 overall, 46.9 ± 18.6 for parents of children <4 years, 47.0 ± 18.6 for parents of children 4-<6 years, and 43.2 ± 19.4 for parents of children
4 Harrington et al 983 Figure 1. Areas parents report most burden. Solid black bars represent <4 years old. Solid white bars represent 4-<6 years old. Black-and-white striped bars represent 6-<7 years old. Figure 2. Areas parents report greatest negative family impact. Solid black bars represent <4 years old. Solid white bars represent 4-<6 years old. Black-and-white striped bars represent 6-<7 years old. aged 6-<7 years (P =.12, Table 2a). The mean total PAID score was not significantly different between parents of females and parents of males (45.2 ± 17.8 vs 46.2 ± 19.9 for females and males, respectively; P =.50), but when stratified by age group, there was a trend toward lower PAID scores in parents of female toddlers compared with parents of male toddlers (42.7 ± 17.8 vs 50.5 ± 18.6, P =.05; Table 2a). Overall, there was a trend toward higher PAID scores in parents with less education and earning less than $75,000 annually (P =.07 and P =.05, respectively), but this trend was not seen when stratified by age group (Table 2a). A higher PAID score was seen among parents of non-white children overall and in the 6-<7-year age group (p<0.01 for both). Mean total PAID scores did not differ among parents of participants using a pump versus injections for insulin delivery (P =.87) or among CGM users versus nonusers (P =.82) when assessed for the overall cohort or when stratified by age group. No significant difference in mean PAID scores was seen among parents of children achieving glycemic target of HbA1c <7.5% versus HbA1c 7.5% (43.9 ± 17.6 vs 46.5 ± 19.3, P =.51), or who had at least one SH event versus no event (47.5 ± 24.3 vs 45.6 ± 18.5, P =.41). A trend toward higher PAID scores was seen in parents of participants who had at least one DKA event versus no event (52.0 ± 19.7 vs 45.4 ± 18.8, P =.06). Results were similar when stratified by age group. Family Impact Results The mean total FIS score was 27.2 ± 19.2 overall, 29.9 ± 19.8 for parents of children <4 years, 28.0 ± 20.5 for parents of children 4-<6 years, and 24.4 ± 16.4 for parents of children aged 6-<7 years (P =.10, Table 2b). The mean total FIS score was not significantly different between parents of females and parents of males (26.0 ± 17.6 vs 28.2 ± 20.5 for females and males, respectively; P =.41, Table 2b).
5 984 Journal of Diabetes Science and Technology 11(5) Table 2a. Mean Problem Areas in Diabetes (PAID) Score According to Demographic and Clinical Characteristics. Overall, N = 597 Ages <4 years, n = 111 Ages 4-<6 years, n = 291 Ages 6-<7 years, n = 195 Mean PAID score Mean PAID score Mean PAID score Mean PAID score Age in years.12 <4 years old 46.9 ± <6 years old 47.0 ± <7 years old 43.2 ± 19.4 Gender Female 45.2 ± ± ± ± 18.2 Male 46.2 ± ± ± ± 20.1 Race/ethnicity < <.01 White non-hispanic 44.8 ± ± ± ± 18.9 Other 49.0 ± ± ± ± 19.5 Annual household income <$75, ± ± ± ± 20.7 $75, ± ± ± ± 18.7 Highest level of parent education High school/ged or less 47.0 ± ± ± ± 21.6 Associate s or bachelor s degree 46.5 ± ± ± ± 18.0 Master s, professional, or doctorate degree 43.1 ± ± ± ± 16.8 Duration of diabetes in years a <3 years 45.7 ± ± ± ± <7 years 46.0 ± ± ± ± 17.8 Reported frequency of self-monitoring blood glucose per day <6 times per day 43.8 ± ± ± ± times per day 46.5 ± ± ± ± 18.8 Continuous glucose monitor user Yes 46.0 ± ± ± ± 19.0 No 45.6 ± ± ± ± 19.5 Pump user Yes 45.6 ± ± ± ± 17.5 No 45.1 ± ± ± ± 21.8 Most recent HbA1c b <7.5% 43.9 ± ± ± ± % 46.5 ± ± ± ± 20.0 Occurrence of at least one SH event in the past 3 months c,d Yes 47.5 ± 24.3 No 45.6 ± 18.5 Occurrence of at least one DKA event in the past 3 months c,d Yes 52.0 ± 19.7 No 45.4 ± 18.8 GED, general education development; SD, standard deviation. a Comparison of total score according to diabetes duration was not completed for the <4-year age group due to small sample size. b Categories are for display purposes only; the is from analyzing as continuous. c The number of participants with events was too small to perform analyses stratified by age. d Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at least one diabetic ketoacidosis (DKA) event in the past 3 months. A trend toward higher family impact of diabetes among households earning <$75,000 annually was seen overall (P =.09) and in the 6-<7-year age group (P =.06) (Table 2b). No differences were seen with regards to race/ethnicity or parental education. There was a trend toward higher total FIS score among both parents of children using a CGM compared to non- CGM users (29.3 ± 18.3 vs 26.2 ± 19.6, P =.01) and among parents of children using a pump compared to multiple daily injections (28.2 ± 18.8 vs 25.3 ± 19.1, P =.03). The trend toward higher FIS scores among parents of pump users was also seen in the <4 year and 6-<7-year age groups (P =.03 and.05, respectively). No significant difference in mean FIS scores was seen among parents of children achieving glycemic target HbA1c of <7.5% versus HbA1c 7.5% (27.5 ± 18.9 vs 27.0 ± 19.3, P =.24), who had at least one SH event versus no event (34.9 ± 28.6 vs 26.6 ± 18.2, P =.21), or who had at least one DKA event versus no event (34.5 ± 24.9 vs 26.8 ± 18.8, P =.14). Results were similar when stratified by age group.
6 Harrington et al 985 Table 2b. Mean Family Impact Survey (FIS) Score According to Demographic and Clinical Characteristics. Overall, N = 586 Ages <4 years, n = 108 Ages 4-<6 years, n = 286 Ages 6-<7 years, n = 192 Mean FIS Score Mean FIS Score Mean FIS Score Mean FIS Score Age in years.10 <4 years old 29.9 ± <6 years old 28.0 ± <7 years old 24.4 ± 16.4 Gender Female 26.0 ± ± ± ± 16.3 Male 28.2 ± ± ± ± 16.5 Race/ethnicity White non-hispanic 26.6 ± ± ± ± 16.5 Other 29.2 ± ± ± ± 15.9 Annual household income <$75, ± ± ± ± 18.7 $75, ± ± ± ± 15.1 Highest level of parent education High school/ged or less 27.5 ± ± ± ± 17.4 Associate s or bachelor s degree 27.7 ± ± ± ± 16.5 Master s, professional, or doctorate degree 25.9 ± ± ± ± 14.9 Duration of diabetes in years a <3 years 26.6 ± ± ± ± <7 years 29.0 ± ± ± ± 17.2 Frequency of self-monitoring blood glucose per day <6 times per day 25.6 ± ± ± ± times per day 27.8 ± ± ± ± 15.8 Continuous glucose monitor user Yes 29.3 ± ± ± ± 15.6 No 26.2 ± ± ± ± 16.6 Pump user Yes 28.2 ± ± ± ± 15.8 No 25.3 ± ± ± ± 17.2 Most recent HbA1c b <7.5% 27.5 ± ± ± ± % 27.0 ± ± ± ± 16.4 Occurrence of at least one SH event in the past 3 months c,d Yes 34.9 ± 28.6 No 26.6 ± 18.2 Occurrence of at least one DKA event in the past 3 months c,d Yes 34.5 ± 24.9 No 26.8 ± 18.8 GED, general education development; SD, standard deviation. a Comparison of total score according to diabetes duration was not completed for the <4-year age group due to small sample size. b Categories are for display purposes only; the is from analyzing as continuous. c The number of participants with events was too small to perform analyses stratified by age. d Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at least one diabetic ketoacidosis (DKA) event in the past 3 months. Conclusions Data for this study were collected from the largest published national (United States) sample of young children under age 7 using previously validated surveys, and the sample was drawn from multiple diabetes treatment centers in geographically diverse areas, which contribute to both the validity and the generalizability of the results. Parents endorsed substantial burdens relating to hypoglycemia, managing blood sugars, and potential complications of poor diabetes management. Notably, only 5% of parents reported feeling discouraged about their child s diabetes treatment plan, suggesting adequate support from their multidisciplinary treatment teams. In terms of family impact, parents reported sleep issues and the need for flexible work arrangements as significant factors. The age span of 3-<7 encompasses many dynamic changes and developmental stages and so it was originally thought burden may be different in each age group, however, our results suggest there is no significant difference in terms of type and frequency of burden between the age periods of toddler, preschoolers, and school aged children. The most common concern endorsed by parents of young children with diabetes was fear of their child having a low blood glucose, which is supported by findings in previous literature. 20
7 986 Journal of Diabetes Science and Technology 11(5) It is important to recognize this as a very common concern in families of young children with type 1 diabetes, as parents may direct their child s diabetes management toward hyperglycemia to reduce risk for hypoglycemia. For example, this worry may impact the behavior of parents of young children, who may reduce insulin doses to alleviate fears of a hypoglycemic event. Thus, providers can address such parental worries in efforts to achieve target glycemic control. Parents also expressed concerns about the long-term impact of type 1 diabetes for their children, with 70% endorsing worry about potential long-term complications. Thus, parents seem to worry about both hypoglycemia and hyperglycemia, feel upset when numbers are off track or out of range, and worry that their child will not be taken care of when the child is not in their care. If a vast majority of parents are worried about both the short- and long-term risks of diabetes, any indication that the child is not in range may cause worry and add to diabetes burden. These parents recognize they are responsible for their child s diabetes care and that, coupled with knowledge of the implications of out of range blood glucose values, can make taking care of diabetes in their young child an arduous task. Sleep interference was also endorsed in these surveys and has been a consistent theme in the literature The sleep quality of both parents and children can be compromised due to the need for diabetes care overnight. Parents who use CGM or remote monitoring technology may check glucose levels on devices frequently. This type of technology may help manage parental fear of hypoglycemia, but may lead to disruption of sleep to check a glucose value and give a corrective dose or low glucose treatment as needed. There were two demographic findings for both diabetes burden and family impact. Higher parental burden was reported among parents of children who are non-white. Minority families may be under additional stress, which may increase diabetes burden. 25 There was also a trend toward higher parental burden among parents with lower education, and a trend toward both higher parental burden and negative family impact among families with lower incomes. Diabetes burden may have a greater impact on families with fewer resources. For example, parents who have less income may experience financial stress due to missed work time and additional medical expenses. The FIS suggested that families who use insulin pumps and CGMs experience more negative impact from their child s diabetes. However, given the cross-sectional nature of these data, we cannot determine causality. In other words, we cannot determine whether families for whom diabetes has a greater negative family impact turn to technology to alleviate the burden, or if wearing advanced diabetes technology devices creates more burden. Future longitudinal research can help assess these associations. There are a few limitations to consider when interpreting the results of this study. First, this was a cross sectional study; thus no causal inferences can be drawn from the results. Second, surveys were self-reported. It is possible that parents who enrolled their child in the registry and completed the entry survey differ in their degree of diabetes-related burden or family impact from parents who chose not to enroll or complete the survey. Further studies using multiple methods of reporting such as survey and qualitative methodology may help to clarify findings with numerous possible interpretations. Third, we chose to conduct the analysis in three different age groups due to the diversity in developmental skills observed across this young age range. A major goal of this study was to understand parents perceptions of burden, and subgrouping the analysis helped us to accomplish this goal. However, the subgroups contained relatively small numbers of respondents; therefore, detecting statistical significance within the different subgroups becomes more challenging. Finally, advanced diabetes technologies are evolving at a rapid pace. During the course of our data collection there was a significant evolution in CGM technology with the advent of remote monitoring and connectivity to cell phones in There may be variability in the results in terms of parental burden and family impact due to some parents having access to newer technology. Indeed, the generalizability of these results will continue to be challenged due to the rapid evolution of technology. This investigation highlights that all families of young children with diabetes experience diabetes related burden and report that diabetes has impact on their family life. Behavioral interventions need to be developed and available to all families that focus on helping the parents of young children understand how usual developmental challenges at different stages impact diabetes management of a young child. Intervention components need to provide strategies, skills, and support integrated into routine care to support parental quality of life related to diabetes management. These interventions must also provide guidance to parents implementing advanced diabetes treatments and technologies. Such interventions may have a positive impact on parents and ultimately on diabetes outcomes for young children with type 1 diabetes. Abbreviations CGM, continuous glucose monitor; DKA, diabetic ketoacidosis; FIS, Family Impact Survey; HbA1c, hemoglobin A1c; PAID-PR, Problem Areas in Diabetes Survey Parent Revised version; SH, severe hypoglycemia; T1D Exchange, T1D Exchange Clinic Registry. Authors Note This article has been substantially revised from the original submission, which was published in the OnlineFirst section of the Journal of Diabetes Science and Technology in February Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
8 Harrington et al 987 Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported through the Leona M. and Harry B. Helmsley Charitable Trust. MV received support from the National Institutes of Health grant K12-DK MEH and BJA also received support from the National Institute of Diabetes and Digestive and Kidney Disease, K References 1. Patton SR, Dolan LM, Smith LB, Thomas IH, Powers SW. Pediatric parenting stress and its relation to depressive symptoms and fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings. 2011;18(4): Piazza-Waggoner C, Modi AC, Powers SW, Williams LB, Dolan LM, Patton SR. Observational assessment of family functioning in families with children who have type 1 diabetes mellitus. J Dev Behav Pediatr. 2008;29(2): Herbert LJ, Clary L, Owen V, Monaghan M, Alvarez V, Streisand R. Relations among school/daycare functioning, fear of hypoglycaemia and quality of life in parents of young children with type 1 diabetes. J Clin Nurs. 2015;24(9-10): Lin HP, Mu PF, Lee YJ. Mothers experience supporting life adjustment in children with T1DM. West J Nurs Res. 2008;30(1):96-110; discussion Smaldone A, Ritholz MD. Perceptions of parenting children with type 1 diabetes diagnosed in early childhood. J Pediatr Health Care. 2011;25(2): Sullivan-Bolyai S, Bova C, Leung K, Trudeau A, Lee M, Gruppuso P. Social Support to Empower Parents (STEP): an intervention for parents of young children newly diagnosed with type 1 diabetes. Diabetes Educ. 2010;36(1): Whittemore R, Jaser S, Chao A, Jang M, Grey M. Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ. 2012;38(4): Pierce JS, Kozikowski C, Lee JM, Wysocki T. Type 1 diabetes in very young children: a model of parent and child influences on management and outcomes [published online ahead of print 2015]. Pediatr Diabetes. doi: /pedi Streisand R, Monaghan M. Young children with type 1 diabetes: challenges, research, and future directions. Curr Diab Rep. 2014;14(9): Grey M, Jaser SS, Whittemore R, Jeon S, Lindemann E. Coping skills training for parents of children with type 1 diabetes: 12-month outcomes. Nurs Res. 2011;60(3): Sullivan-Bolyai S, Deatrick J, Gruppuso P, Tamborlane W, Grey M. Constant vigilance: mothers work parenting young children with type 1 diabetes. J Pediatr Nurs. 2003;18(1): Monaghan M, Hilliard ME, Cogen FR, Streisand R. Supporting parents of very young children with type 1 diabetes: results from a pilot study. Patient Educ Couns. 2011;82(2): Monaghan M, Sanders RE, Kelly KP, Cogen FR, Streisand R. Using qualitative methods to guide clinical trial design: parent recommendations for intervention modification in type 1 diabetes. J Fam Psychol. 2011;25(6): Streisand R, Herbert L, Owen V, Monaghan M. Use of parent consultants in a telehealth intervention for parents of children newly diagnosed with type 1 diabetes. J Mob Technol Med. 2012;1(4S): Commissariat P, Whitehouse A, Boyle C, et al. Parent-reported perceptions of educational opportunities to alleviate burden associated with the management of type 1 diabetes (T1D) in children <8 years old. Pediatr Diabetes. 2016;17(suppl 24): Levy W, Whitehouse AL, Anderson BJ, et al. Benefits and barriers of continuous glucose monitoring (CGM) in children <8 with type 1 diabetes (T1D). Diabetes. 2017;66(suppl 1):A Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2012;97(12): Markowitz JT, Volkening LK, Butler DA, Antisdel-Lomaglio J, Anderson BJ, Laffel LM. Re-examining a measure of diabetes-related burden in parents of young people with type 1 diabetes: the Problem Areas in Diabetes Survey Parent Revised version (PAID-PR). Diabet Med. 2012;29(4): Katz ML, Volkening LK, Dougher CE, Laffel LM. Validation of the diabetes family impact scale: a new measure of diabetesspecific family impact. Diabet Med. 2015;32(9): Van Name MA, Hilliard ME, Boyle CT, et al. Nighttime is the worst time: parental fear of hypoglycemia in young children with type 1 diabetes (T1D) [published online ahead of print April 21, 2017]. Pediatr Diabetes. doi: /pedi Herbert LJ, Monaghan M, Cogen F, Streisand R. The impact of parents sleep quality and hypoglycemia worry on diabetes self-efficacy. Behav Sleep Med. 2015;13(4): Landau Z, Rachmiel M, Pinhas-Hamiel O, et al. Parental sleep quality and continuous glucose monitoring system use in children with type 1 diabetes. Acta Diabetol. 2014;51(3): Monaghan M, Herbert LJ, Cogen FR, Streisand R. Sleep behaviors and parent functioning in young children with type 1 diabetes. Child Health Care. 2012;41(3): Monaghan MC, Hilliard ME, Cogen FR, Streisand R. Nighttime caregiving behaviors among parents of young children with type 1 diabetes: associations with illness characteristics and parent functioning. Fam Syst Health. 2009;27(1): Meyer IH. Prejudice as stress: conceptual and measurement problems. Am J Public Health. 2003;93(2):
Youth-Perceived Burden of Type 1 Diabetes: Problem Areas in Diabetes Survey Pediatric Version (PAID-Peds)
583506DSTXXX10.1177/1932296815583506Journal of Diabetes Science and TechnologyMarkowitz et al research-article2015 Original Article Youth-Perceived Burden of Type 1 Diabetes: Problem Areas in Diabetes
More informationEvaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry
663963DSTXXX10.1177/1932296816663963Journal of Diabetes Science and TechnologyWong et al research-article2016 Original Article Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange
More informationUTILIZING ACTIGRAPHY TO EXAMINE SLEEP IN YOUNG CHILDREN WITH TYPE 1 DIABETES
UTILIZING ACTIGRAPHY TO EXAMINE SLEEP IN YOUNG CHILDREN WITH TYPE 1 DIABETES Jadienne Lord, B.A. Beth Malow, M.D. Sarah Jaser, Ph.D. Vanderbilt University Medical Center Ian M. Burr Division of Pediatric
More informationT he advent in the 1980s of meters for
Epidemiology/Health Services Research O R I G I N A L A R T I C L E Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1C Levels in T1D Exchange Clinic
More informationCLINICAL UTILITY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 1 DIABETES: A MACEDONIAN REPORT
University Department of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Sv. Kiril I Metodij University, Skopje, Macedonia Scientific Paper Received: February 19, 2007 Accepted: March
More informationLessons From The Type 1 Diabetes Exchange
Lessons From The Type 1 Diabetes Exchange Andrew Ahmann, MD Harold Schnitzer Diabetes Health Center at OHSU Presenter Disclosure Information In compliance with the accrediting board policies, the American
More informationThe Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections
8/5/217 The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections Richard M. Bergenstal, MD Executive Director International Diabetes Center at Park Nicollet Minneapolis,
More informationSubheadings adapted to the terminology in the respective databases were included in the searches.
Table 1. Literature searches related to the literature review (Chapter 2) * Search terms ** Diabetes Mellitus, Type 1 OR type 1 diabetes + parent OR parenting + hypoglycemia + fear Diabetes Mellitus, Type
More informationFamily Teamwork and Type 1 diabetes. Barbara J. Anderson, Ph.D. Professor of Pediatrics Baylor College of Medicine Houston, TX
Family Teamwork and Type 1 diabetes Barbara J. Anderson, Ph.D. Professor of Pediatrics Baylor College of Medicine Houston, TX Lessons from Research: What are the family factors that predict optimal adherence
More informationDiabetes Management: Current High Tech Innovations
Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:
More informationSee accompanying articles, pp. 968, 979, 989, 997, 1008, 1016, 1030, and 1036.
Diabetes Care Volume 38, June 2015 971 CurrentStateofType1Diabetes Treatment in the U.S.: d Data From the T1D Exchange Clinic Registry Diabetes Care 2015;38:971 978 DOI: 10.2337/dc15-0078 Kellee M. Miller,
More informationParental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion
Pediatric Diabetes 2007: 8: 362 368 All rights reserved # 2007 The Authors Journal compilation # 2007 Blackwell Munksgaard Pediatric Diabetes Original Article Parental fear of hypoglycemia: young children
More informationPsychological Reactions Associated With Continuous Glucose Monitoring in Youth
638109DSTXXX10.1177/1932296816638109Journal of Diabetes Science and TechnologyPatton and Clements research-article2016 Special Section Psychological Reactions Associated With Continuous Glucose Monitoring
More informationT1D Exchange Clinic Registry: 25,000 strong! What is it and what have we learned to date? Georgeanna J Klingensmith, MD Barbara Davis Center
T1D Exchange Clinic Registry: 25,000 strong! What is it and what have we learned to date? Georgeanna J Klingensmith, MD Barbara Davis Center T1D Exchange Mission and Goals Improve outcomes of people touched
More informationTHE INFLUENCE OF PSYCHOSOCIAL AND TREATMENT-RELATED VARIABLES ON ADHERENCE AND METABOLIC CONTROL IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
THE INFLUENCE OF PSYCHOSOCIAL AND TREATMENT-RELATED VARIABLES ON ADHERENCE AND METABOLIC CONTROL IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS Lene J. Kristensen, Niels H. Birkebaek, Anne H. Mose, Morten
More information4/18/19. Emerging Adulthood defined as the post adolescence age range of
Transition of Care from Pediatric to Adult Endocrinology William Martin, PA-C, CDE Providence Pediatric Endocrinology & Diabetes Spokane, WA April 27, 2019 Notice of Requirements for Successful Completion:
More informationWhat is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming
The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,
More information8/8/2015. The Educational Needs of Fathers of Youth with Diabetes: A Mixed Methods Study. Diabetes Management
Anastasia Albanese-O Neill PhD, ARNP, CDE Assistant Professor University of Florida, College of Nursing Gainesville, FL Disclosure to Participants Notice of Requirements For Successful Completion Please
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationResearch Article Measures of Adherence and Challenges in Using Glucometer Data in Youth with Type 1 Diabetes: Rethinking the Value of Self-Report
Hindawi Diabetes Research Volume 2017, Article ID 1075428, 4 pages https://doi.org/10.1155/2017/1075428 Research Article Measures of Adherence and Challenges in Using Glucometer Data in Youth with Type
More informationFebruary 19, Dear Medical Director:
141 Northwest Point Blvd Elk Grove Village, IL 60007-1019 Phone: 847/434-4000 Fax: 847/434-8000 E-mail: kidsdocs@aap.org www.aap.org Executive Committee President Sandra G. Hassink, MD, FAAP President-Elect
More informationFlorida Network Symposium
Katrina J. Ruedy, MSPH John W. Lum, MS Jaeb Center for Health Research NE Florida Network Symposium In Conjunction with The 28th Annual Clinical Conference on Diabetes Jaeb Center for Health Research (JCHR)
More informationUpdate on Continuous Glucose Monitoring (CGM) Technology in Diabetes. Elena Toschi, MD November 12, 2016
Update on Continuous Glucose Monitoring (CGM) Technology in Diabetes Elena Toschi, MD November 12, 2016 Presenter Disclosure Information Elena Toschi, MD No financial disclosure Objectives: Use of CGM
More informationKeywords diabetes software, insulin, self-management, self-monitoring of blood glucose, SMBG
557188DSTXXX10.1177/1932296814557188Journal of Diabetes Science and TechnologyHinnen et al research-article2014 Original Article Use of Diabetes Data Management Software Reports by Health Care Providers,
More informationPREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)
PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly
More informationPSYCHOSOCIAL EFFECTS OF MANAGING CGMS. Megan Purser, PhD
PSYCHOSOCIAL EFFECTS OF MANAGING CGMS Megan Purser, PhD DEPARTMENT OF PEDIATRICS OF PEDIATRICS Diabetes Management of the School-Aged Child Provided by Texas Children s Hospital Provider #18-267764-A February
More informationEnsuring Safe Physical Activity in Children and Adolescents With Type 1 Diabetes
Ensuring Safe Physical Activity in Children and Adolescents With Type 1 Diabetes FACULTY ADVISOR Lori Laffel, MD, MPH Professor, Pediatrics Harvard Medical School Chief, Pediatric, Adolescent and Young
More informationOriginal Article. Pediatric Diabetes
Pediatric Diabetes 2009: 10: 455 460 doi: 10.1111/j.1399-5448.2009.00506.x All rights reserved # 2009 The Authors Journal compilation # 2009 Blackwell Munksgaard Pediatric Diabetes Original Article Feeding
More informationWhen Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
When Will CGM Replace SMBG? Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer, the JAEB Center
More informationDiabetes Management in Toddlers/Preschoolers (<6 yo)
Diabetes Management in Toddlers/Preschoolers (
More informationFrom Childhood to Adulthood: Young Adult Transitions in Diabetes Care
From Childhood to Adulthood: Young Adult Transitions in Diabetes Care Lori Laffel, MD, MPH Chief, Pediatric, Adolescent and Young Adult Section Investigator, Genetics and Epidemiology Section Joslin Diabetes
More informationPediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis
Pediatric Diabetes 2014: 15: 287 293 doi: 10.1111/pedi.12068 All rights reserved 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Pediatric Diabetes Original Article Pediatric diabetes consortium
More informationAdherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice
Diabetes Management For reprint orders, please contact: reprints@futuremedicine.com Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice
More informationThe Influence of Diabetes Distress on a Clinician-Rated Assessment of Depression in Adults with Type 1 Diabetes
The Influence of Diabetes Distress on a Clinician-Rated Assessment of Depression in Adults with Type 1 Diabetes Molly L. Tanenbaum, M.A. Persis Commissariat, B.A. Sabrina A. Esbitt, M.A. Ferkauf Graduate
More informationAn Evaluation of the Barriers to Patient use of Glucometer Control Solutions: A Survey of Patients, Pharmacists, and Providers
AADE14 ANNUAL MEETING & EXHIBITION AUGUST 6-9, 2014 ORLANDO, FL An Evaluation of the Barriers to Patient use of Glucometer s: A Survey of Patients, Pharmacists, and Providers Katherine S. O Neal, Pharm.D.,
More informationImprovement and Emergence of Insulin Restriction in Women With Type 1 Diabetes
Improvement and Emergence of Insulin Restriction in Women With Type 1 Diabetes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bergenstal RM, Klonoff DC, Garg SK, et al. -based insulin-pump
More informationImproving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care
Diabetes Ther (2016) 7:473 481 DOI 10.1007/s13300-016-0176-9 ORIGINAL RESEARCH Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care Brian
More informationRayzel Shulman MD, PhD CAHSPR May 10, 2016
+ Low Socioeconomic Status is Associated with Adverse Events in Children and Teens on Insulin Pumps Under a Universal Access Program: A population-based Cohort Study Rayzel Shulman MD, PhD CAHSPR May 10,
More informationExercise Prescription in Type 1 Diabetes
Exercise Prescription in Type 1 Diabetes Michael Riddell, PhD Professor, Muscle Health Research Centre and School of Kinesiology & Health Science, York University Senior Scientist, LMC Diabetes & Endocrinology,
More informationORIGINAL INVESTIGATION. Use of a Blood Glucose Monitoring Manual to Enhance Monitoring Adherence in Adults With Diabetes
ORIGINAL INVESTIGATION Use of a Blood Glucose Monitoring Manual to Enhance Monitoring Adherence in Adults With Diabetes A Randomized Controlled Trial Elaine C. Moreland, MD; Lisa K. Volkening, BA; Margaret
More informationThe prevalence of psychological and behavioral changes among children and adolescents with diabetes in Makkah, Saudi Arabia.
Curr Pediatr Res 2018; 22 (1): 9-15 ISSN 0971-9032 www.currentpediatrics.com The prevalence of psychological and behavioral changes among children and adolescents with diabetes in Makkah, Saudi Arabia.
More informationFood Insecurity and the Double Burden of Malnutrition
Food Insecurity and the Double Burden of Malnutrition Rafael Pérez-Escamilla, PhD Department of Social and Behavioral Sciences Yale School of Public Health New Haven CT USA @rperezescamilla Funding declaration:
More informationObjectives. Texas Children s Hospital Diabetes Care Center Houston, TX. Older Developmental Theories of the Post-High School Period
Transitioning from Pediatric to Adult Diabetes Care: Developmental and Psychological Dimensions Barbara J. Anderson, Ph.D. Professor of Pediatrics Baylor College of Medicine Houston, TX Texas Children
More informationNutrition for Children with T1 Diabetes. Gail Spiegel, MS RD CDE Senior Instructor
Nutrition for Children with T1 Diabetes Gail Spiegel, MS RD CDE Senior Instructor 2018 ATDC Conference: Conflict of Interest I have no conflicts of Interest. I will not be speaking on off-label topics.
More informationChapter 1 - General introduction.
Chapter 1 - General introduction. 9 Chapter 1 - General Introduction This thesis reports on six studies that were conducted to get a better understanding of the influence of emotional factors on self-care
More informationA Study of Patient Experience Using a Blood Glucose Meter With an In-Built Insulin Dose Calculator
532489DSTXXX10.1177/1932296814532489Journal of Diabetes Science and TechnologyRamtoola et al research-article2014 Original Article A Study of Patient Experience Using a Blood Glucose Meter With an In-Built
More informationSafety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes
Emerging Treatments and Technologies O R I G I N A L A R T I C L E Safety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes LESLIE P. PLOTNICK, MD 1 LORETTA M.
More informationJames J. Chamberlain, MD 1, Dana Dopita, RN, MSN, CDE 1, Emily Gilgen, RD, CD, CDE 1, and Annie Neuman, MPA, PA-C 1.
604633DSTXXX10.1177/1932296815604633Journal of Diabetes Science and TechnologyChamberlain et al research-article2015 Original Article Impact of Frequent and Persistent Use of Continuous Glucose Monitoring
More informationDiabetes Care Publish Ahead of Print, published online April 7, 2017
Diabetes Care 1 The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial DOI: 10.2337/dc17-0133
More informationDEMYSTIFYING INSULIN THERAPY
DEMYSTIFYING INSULIN THERAPY ASHLYN SMITH, PA-C ENDOCRINOLOGY ASSOCIATES SCOTTSDALE, AZ SECRETARY, AMERICAN SOCIETY OF ENDOCRINE PHYSICIAN ASSISTANTS ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING
More informationDexcom Current and Future Technology Innovations. Jorge Valdes Chief Technical Officer
Dexcom Current and Future Technology Innovations 2015 Jorge Valdes Chief Technical Officer G5 App Sensor (Same as G4) Indicated for adults and children down to Age 2 years Tiny insertion needle (26Ga)
More informationDiabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD
Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections Aaron Michels MD Outline SMBG & CGM by age group JDRF CGM Trial Sensor Augmented Insulin Pump Therapy for A1c Reduction
More informationQuarterly Visits with Glycated Hemoglobin Monitoring: The Sweet Spot for Glycemic Control in Youth with Type 1 Diabetes
Page 1 of 16 Diabetes Care 1 Quarterly Visits with Glycated Hemoglobin Monitoring: The Sweet Spot for Glycemic Control in Youth with Type 1 Diabetes Running title: Visit Frequency and Glycemic Control
More informationComparing the use of SMBG vs. CGM data to Optimize Glucose Control in T2DM
Comparing the use of SMBG vs. CGM data to Optimize Glucose Control in T2DM For the first time using CGM to assess glucose control achieved in both groups Richard M. Bergenstal, MD International Diabetes
More informationRole of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study ibgstar Ò in Type 1 Diabetes Management
Diabetes Ther (2017) 8:811 819 DOI 10.1007/s13300-017-0272-5 ORIGINAL RESEARCH Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study ibgstar Ò in Type
More informationPromoting Parent Engagement and Responding to Problematic Adherence in Type 1 Diabetes
Promoting Parent Engagement and Responding to Problematic Adherence in Type 1 Diabetes Amy Hughes Lansing, PhD Licensed Clinical Psychologist Assistant Professor, Psychology, UNR Agenda Where kids and
More informationDiabetes Care Publish Ahead of Print, published online December 20, 2007
Diabetes Care Publish Ahead of Print, published online December 20, 2007 FreeStyle Navigator Continuous Glucose Monitoring System Use in Children with Type 1 Diabetes using glargine-based multiple daily
More informationPatrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation
Patrick J. Sullivan Chief Executive Officer January 9, 2018 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationDeaf-Blind Census. Instructions, Definitions, and Reporting Materials
Deaf-Blind Census Instructions, Definitions, and Reporting Materials Georgia Sensory Assistance Project in collaboration with The Georgia Department of Education Due Date: December 18, 2015 National Deaf-Blind
More informationInsulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction
More informationEffectiveness Of A Diabetic Ketoacidosis Prevention Intervention In Children With Type 1 Diabetes
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2015 Effectiveness Of A Diabetic Ketoacidosis Prevention Intervention
More informationThe National Council on the Aging May 1999
The National Council on the Aging May 1999 Study conducted by the Seniors Research Group, An alliance between The National Council on the Aging and Market Strategies Inc. The National Council on the Aging
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) Page 1 of 7, DMMP This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with
More informationOriginal Article. Nicholas B. Argento, MD 1 ; Katherine Nakamura, PhD 2 ABSTRACT
Original Article Nicholas B. Argento, MD 1 ; Katherine Nakamura, PhD 2 ABSTRACT Objective: Little information is available on personal real-time continuous glucose monitoring (PCGM) in patients 65 years
More informationTelemedicine for the Care of Youth with Type 1 Diabetes
Telemedicine for the Care of Youth with Type 1 Diabetes R. Paul Wadwa, MD Associate Professor of Pediatrics Director of Telemedicine Medical Director, Pediatric Division Barbara Davis Center for Childhood
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated
More informationDIAGNOSIS OF DIABETES NOW WHAT?
DIAGNOSIS OF DIABETES NOW WHAT? DISCUSS GOALS FOR DIABETES CARE IDENTIFY COMMON COMPLIANCE- ADHERENCE ISSUES DESCRIBE TECHNOLOGY TO ASSIST AND / OR IMPROVE DIABETES CARE WHAT DO WE WANT OUR PATIENTS TO
More informationCounting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice
Welcome to Allied Health Telehealth Virtual Education Counting the Carbs, Fats and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Dr Carmel Smart, PhD Senior Specialist Paediatric
More informationNo disclosures 8/4/2017. Cari Berget RN, MPH, CDE Clinical Research Nurse, Diabetes Educator. Disclosure to Participants
Cari Berget RN, MPH, CDE Clinical Research Nurse, Diabetes Educator Barbara Davis Center for Diabetes Aurora, CO Disclosure to Participants No disclosures FEAR OF HYPOGLYCEMIA AND IMPLICATIONS FOR CLINICAL
More informationCon - SMBG Should be the Standard of Care in All Patients with Type 2 Diabetes
JUNE 9 13, 2006 WASHINGTON, DC Con - SMBG Should be the Standard of Care in All Patients with Type 2 Diabetes Antonio Nicolucci, MD Department of Clinical Pharmacology and Epidemiology Consorzio Mario
More informationThe artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes
The artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes Roman Hovorka PhD FMedSci University of Cambridge, UK Duality of interest declaration Advisory Panel: Research
More informationDiabetes Care 27: , 2004
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E The Blood Glucose Monitoring Communication Questionnaire An instrument to measure affect specific to blood glucose monitoring
More informationDiabetes distress 7 A s model
Diabetes and emotional health: A toolkit for health s supporting adults with type 1 or type 2 diabetes Diabetes distress 7 A s model AWARE Be AWARE that people with diabetes may experience diabetes distress
More informationORIGINAL ARTICLE. Use of Freestyle Libre Pro TM Flash Glucose Monitoring System in Different Clinical Situations at a Diabetes Centre
18 Journal of The Association of Physicians of India Vol. 65 August 217 ORIGINAL ARTICLE Use of Freestyle Libre Pro TM Flash itoring System in Different Clinical Situations at a Diabetes Centre Bangalore
More informationPsychological Well-Being of Carers of Children with Type 1 Diabetes: A Comparison with Carers of Children without a Chronic Condition
96 Original Article THIEME Psychological Well-Being of Carers of Children with Type 1 Diabetes: A Comparison with Carers of Children without a Chronic Condition Francesca E. Thomson 1 Philip B. Bergman
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationHemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry
Pediatric Diabetes 2016: 17: 327 336 doi: 10.1111/pedi.12295 All rights reserved 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Pediatric Diabetes Original Article Hemoglobin A1c (HbA1c)
More information2-1-1 as Gateway to Better Health Outcomes for Young Children
2-1-1 as Gateway to Better Health Outcomes for Young Children AIRS Conference, May 24, 2017 Patricia Herrera, MS 2-1-1 Los Angeles County Bergen Nelson, MD, MS Children s Hospital of Richmond Virginia
More informationDiabetes Care Publish Ahead of Print, published online February 25, 2010
Diabetes Care Publish Ahead of Print, published online February 25, 2010 Undertreatment Of Mental Health Problems In Diabetes Undertreatment Of Mental Health Problems In Adults With Diagnosed Diabetes
More informationSchool of Health Science & Nursing, Wuhan Polytechnic University, Wuhan , China 2. Corresponding author
2017 International Conference on Medical Science and Human Health (MSHH 2017) ISBN: 978-1-60595-472-1 Association of Self-rated Health Status and Perceived Risk Among Chinese Elderly Patients with Type
More informationType 1 Diabetes in Children and Adolescents
Type 1 Diabetes in Children and Adolescents Joseph Wolfsdorf Division of Endocrinology Boston Children s Hospital Harvard Medical School joseph.wolfsdorf@childrens.harvard.edu I have no relevant financial
More informationPsychological characteristics of Korean children and adolescents with type 1 diabetes mellitus
Original article http://dx.doi.org/10.6065/apem.2013.18.3.122 Ann Pediatr Endocrinol Metab 2013;18:122-127 Psychological characteristics of Korean children and adolescents with type 1 diabetes mellitus
More informationChoosing a screening tool to assess disordered eating in adolescents with type 1 diabetes mellitus
Choosing a screening tool to assess disordered eating in adolescents with type 1 diabetes mellitus Helen d Emden, Brett McDermott, Kristen Gibbons, Mark Harris, Andrew Cotterill PII: S1056-8727(14)00265-7
More informationAbout the Highmark Foundation
About the Highmark Foundation The Highmark Foundation, created in 2000 as an affiliate of Highmark Inc., is a charitable organization and a private foundation that supports initiatives and programs aimed
More informationOriginal Article. (This manuscript was submitted on 9 February Following blind peer review, it was accepted for publication on 6 June 2012)
483331PED0Supp. 10.1177/1757975913483331D. Trouilloud and J. Regnier 013 Therapeutic education among adults with type diabetes: effects of a three-day intervention on perceived competence, self-management
More informationPaolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico
Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna Ipoglicemie e Monitoraggio Glicemico Management of Hypoglycaemia.if hypoglycemia is a problem, the principles
More informationControl of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim
Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine Conflict of interest
More informationInsulin Pumps and Glucose Sensors in Diabetes Management
Diabetes Update+ 2014 Congress Whistler, British Columbia Friday March 21, 2014ǀ 8:15 8:45 am Insulin Pumps and Glucose Sensors in Diabetes Management Bruce A Perkins MD MPH Division of Endocrinology Associate
More informationORIGINAL REPORTS: DIABETES
ORIGINAL REPORTS: DIABETES THE RELATIVE IMPACT OF DIABETES DISTRESS VS DEPRESSION ON GLYCEMIC CONTROL IN HISPANIC PATIENTS FOLLOWING A DIABETES SELF-MANAGEMENT EDUCATION INTERVENTION Objectives: Studies
More informationNEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP
NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP No commercial support or sponsorship was received for this project I have nothing to disclose OBJECTIVES Identify at
More informationAnneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?
More informationTarget Audience. approach this patient case scenario, including identifying an
Activity Overview In this case-based webcast, meet LaWanda, a 57-year-old woman with type 2 diabetes. Her glycated hemoglobin (HbA1C) is 8.4%, she is currently taking basal insulin and fast-acting insulin,
More informationDisplay of Glucose Distributions by Date, Time of Day, and Day of Week: New and Improved Methods
Journal of Diabetes Science and Technology Volume 3, Issue 6, November 2009 Diabetes Technology Society ORIGINAL ARTICLES Display of Glucose Distributions by Date, Time of Day, and Day of Week: New and
More informationArtificial Pancreas Device Systems. Populations Interventions Comparators Outcomes Individuals: With type 1 diabetes
Protocol Artificial Pancreas Device Systems Medical Benefit Effective Date: 07/01/18 Next Review Date: 01/20 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18, 05/18, 01/19 Preauthorization
More informationADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values - New Treatment Guidelines Will Now be Needed
529638DSTXXX10.1177/1932296814529638Journal of Diabetes Science and TechnologyKlonoff research-article2014 Editorial ADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values
More informationType I Diabetes in Children: Facilitating Adherence to Medical Regimens
Chapter 17 Type I Diabetes in Children: Facilitating Adherence to Medical Regimens Laura Nabors and Jenny Bartz Additional information is available at the end of the chapter http://dx.doi.org/10.5772/52283
More informationInitiation of insulin pump therapy in children at diagnosis of type 1 diabetes resulted in improved long-term glycemic control
Pediatric Diabetes 2016 doi: 10.1111/pedi.12357 All rights reserved 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Pediatric Diabetes Original Article Initiation of insulin pump therapy
More informationType 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER
Type 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER Yes! Is Type 2 diabetes the same in kids as in adults? And No!
More informationDISCOVER THE POWER OF CONNECTION MINIMED 640G
DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Have you just been diagnosed with insulin dependent diabetes? Perhaps you ve been on multiple daily injection therapy
More information